Clinical trials

  • BREPOCITINIB TOSILATE for Non-infectious uveitis | Intermediate uveitis | Posterior uveitis | Panuveitis
  • Perflubutane for Breast cancer | Melanoma | Head and neck cancer
  • RELATLIMAB for Breast cancer
  • BISACODYL for Fecal incontinence
  • RITUXIMAB for Epstein-Barr virus infection | Post-transplant lymphoproliferative disorder | Kidney transplant recipient
  • ROGINOLISIB for Myelofibrosis (refractory to JAK inhibitors)
  • AGMB-101 for Liver cirrhosis
  • Acetylsalicylic acid for Colorectal cancer
  • LUSPATERCEPT for Myelodysplastic syndrome (MDS) - lower-risk|Myelodysplastic syndrome with ring sideroblasts (MDS-RS)
  • SAR442970 for Ulcerative colitis
  • NIVOLUMAB for Classical Hodgkin lymphoma (refractory or relapsed)
  • DURVALUMAB for Locally advanced rectal cancer